Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Immunology Miniatures

Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma

Christopher A. Barker, Michael A. Postow, Shaheer A. Khan, Kathryn Beal, Preeti K. Parhar, Yoshiya Yamada, Nancy Y. Lee and Jedd D. Wolchok
Christopher A. Barker
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Postow
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaheer A. Khan
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Beal
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Preeti K. Parhar
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiya Yamada
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Y. Lee
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jedd D. Wolchok
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/2326-6066.CIR-13-0082 Published August 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: July 2013 to January 2021

AbstractFull-text HTMLPDF
Total718741203168

Cited By

Article Information

Volume 1, Issue 2, pp. 92-98

DOI 
https://doi.org/10.1158/2326-6066.CIR-13-0082
PubMed 
24777500

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received June 21, 2013
  • Accepted June 27, 2013
  • Published first July 25, 2013.

Article Versions

  • Previous version (July 25, 2013 - 06:59).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2013 American Association for Cancer Research.

Author Information

  1. Christopher A. Barker1,
  2. Michael A. Postow2,
  3. Shaheer A. Khan2,
  4. Kathryn Beal1,
  5. Preeti K. Parhar1,
  6. Yoshiya Yamada1,
  7. Nancy Y. Lee1, and
  8. Jedd D. Wolchok2,3,4,5
  1. Authors' Affiliations: 1Department of Radiation Oncology, 2Melanoma and Sarcoma Service, Department of Medicine, 3Ludwig Institute for Cancer Research, and 4Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center; and 5Weill Cornell Medical College, New York, New York
  1. Corresponding Author:
    Christopher A. Barker, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 22, New York, NY 10065. Phone: 1-212-639-8168; Fax: 1-212-717-3104; E-mail: barkerc{at}mskcc.org
  1. C.A. Barker and M.A. Postow contributed equally to this work.

View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 1 (2)
August 2013
Volume 1, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
Christopher A. Barker, Michael A. Postow, Shaheer A. Khan, Kathryn Beal, Preeti K. Parhar, Yoshiya Yamada, Nancy Y. Lee and Jedd D. Wolchok
Cancer Immunol Res August 1 2013 (1) (2) 92-98; DOI: 10.1158/2326-6066.CIR-13-0082

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
Christopher A. Barker, Michael A. Postow, Shaheer A. Khan, Kathryn Beal, Preeti K. Parhar, Yoshiya Yamada, Nancy Y. Lee and Jedd D. Wolchok
Cancer Immunol Res August 1 2013 (1) (2) 92-98; DOI: 10.1158/2326-6066.CIR-13-0082
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Immune and Genomic Relationships in Melanoma Subtypes
  • Probiotic Therapy Impacts Cancer Immunotherapy
  • Visualization of Ibrutinib-Induced CLL Compartment Shift
Show more Cancer Immunology Miniatures
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement